Acute quadriplegic myopathy with thick filament loss spares moving muscles: An autopsy study

Acta Myologica

Volumn 25, Issue 2, 2006, Pages 62-67

  Magda, P ^a   Sander, H W ^a,b,c,d   Schliselfeld, L H ^b,c   Danon, Moris J ^c,d  

^a ST VINCENT S HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Acute quadriplegic myopathy; Thick filament loss

Indexed keywords

ATRACURIUM; AZATHIOPRINE; CARNITINE; CREATINE KINASE; GLYCOGEN; LIPID; METHYLPREDNISOLONE; MITOCHONDRIAL ENZYME; PREDNISONE;

ACUTE DISEASE; AREFLEXIA; ARTICLE; AUTOPSY; BICEPS BRACHII MUSCLE; CHRONIC DISEASE; CREATINE KINASE BLOOD LEVEL; DELTOID MUSCLE; DIAPHRAGM MUSCLE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ELECTROMYOGRAPHY; ELECTRON MICROSCOPY; ESTERIFICATION; FROZEN SECTION; GLYCOGEN MUSCLE LEVEL; HEART MUSCLE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; INTERCOSTAL MUSCLE; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; MUSCLE BIOPSY; MYOFILAMENT; MYOPATHY; NERVE BIOPSY; NEUROLOGIC EXAMINATION; PERIPHERAL NERVE; POLYMYOSITIS; QUADRIPLEGIA; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SKIN BIOPSY; SPINAL CORD; SURAL NERVE;

ADULT; AUTOPSY; HUMANS; MALE; MUSCLE, SKELETAL; MUSCULAR DISEASES; QUADRIPLEGIA;

EID: 33947394020     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sander HW, Danon MJ, Golden M. Quadriplegic areflexic ICU illness: selective thick filament loss and normal nerve histology. Muscle Nerve 2002;26:499-505.
2. Christiansen RZ, Bremer J. Active transport of butyrobetaine and carnitine into isolated liver cells. Biochem Biophys Acta 1976;448:562-77.
3. Di Mauro S, Serenella S, Massimo Z, et al. Cytochrome c oxidase deficiency in Leigh Syndrome. Ann Neurol 1987;22:498-506.
4. McGarry JD, Foster DW. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res 1976;17:277-84.
5. Schliselfeld LH, Danon MJ. Use of fructose-2, 6-diphosphate to assay for phosphofuctokinase activity in human muscle. Clin Biochem 1996;29:79-83.
6. Wilkinson DA, Tonin P, Shanske S, et al. Clinical and biochemical features of 10 adult patients with muscle phosphorylase kinase deficiency. Neurology 1994;44:461-6.
7. st autopsy report. Neurology 1998;50(4):A205.
8. Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998;43:171-9.
9. DuBois DC, Almon RR. Disuse atrophy of skeletal muscle is associated with an increase in number of glucocorticoid receptors. Endocrinology 1980;107:1649-51.
10. Goldberg AL, Goodman HM. Relationship between cortisone and muscle work in determining muscle size. J Physiol 1969;200:667-75.
11. Fernandez-Sola J, Cusso R, Picado C, et al. Patients with chronic glucocorticoid treatment develop changes in muscle glycogen metabolism. J Neurol Sci 1993;117:103-6.
12. Schliselfeld LH, Danon MJ. Muscle glycogen of steroid myopathy patients. J Neurol Sci 1996;136:192-3.
13. Blumbergs PC, Byrne E, Kakulas BA. Polymyositis presenting with respiratory failure. J Neurol Sci 1984;65:221-9.
14. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-9.
15. Jerusalem F, Spiess H., Baumgartner G. Lipid storage myopathy with normal carnitine levels. J Neurol Sci 1975;24:273-82.
16. Odusole K, Karpati G, Carpenter S. An experimental morphometric study of neutral lipid accumulation in skeletal muscles. Muscle Nerve 1981;4:3-9.
17. Ohira Y, Yoshinaga T, Nonaka I, et al. Histochemical responses of human soleus muscle fibers to long term bedrest with or without countermeasures. JPN J Physiol 2000;50:41-7.